Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 74Terminated 20Withdrawn 5Unknown 4Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Other solid neoplasm 1Gastrointestinal 1CNS 1

Conditions

Neoplasms 2Relapsed Pediatric Solid Tumor 1Glioma 1Gastrointestinal Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × vandetanib × Clear all
NCT02239952 2020-10-08

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Amsterdam UMC, location VUmc

Phase NA Unknown
15 enrolled
CNS

Glioma, Neoplasms

NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Samsung Medical Center

Phase 2 Unknown
90 enrolled
Other solid neoplasm

Relapsed Pediatric Solid Tumor

NCT02013089 2016-08-30

GITIC

Sun Yat-sen University

Phase NA Unknown
50 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT02530411 2015-08-21

FURVA

Velindre NHS Trust

Phase 2 Unknown
160 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡